職名 講師
氏名 まつもと たけし
松本 剛史
生年月 1968.06
所属 部局 附属病院
学科・専攻 輸血・細胞治療部
講座  
教育研究分野  
TEL  
FAX 059-231-5216
E-mail matsutak@clin...............
個人のホームページ  
学歴 山口大学医学部医学科 学士課程 (~1997年03月) 卒業・修了
三重大学大学院医学系研究科 博士課程・博士後期課程 (~2006年12月) 卒業・修了
学位 2006.12 博士(医学) 三重大学
所属学会 日本血液学会 日本血栓止血学会 日本輸血・細胞治療学会 日本内科学会 日本エイズ学会 日本検査血液学会 日本臨床検査医学会 International Society on Thrombosis and Haemostasis The World Federation of Hemophilia 日本感染症学会
社会活動  
職歴 1998~ 三重大学医学部第二内科入局
2007.04~2008.03 三重大学医学部附属病院 内科系診療科 医員
2008.04~2008.05 三重大学医学部附属病院 輸血部  医員
2008.06~2017.09 三重大学医学部附属病院 輸血部 助教
2008.12~2017.09 三重大学医学部附属病院 輸血部 副部長
2017.10~2021.03 三重大学医学部附属病院 輸血・細胞治療部 助教・副部長
2021.04~    三重大学医学部附属病院 輸血・細胞治療部 講師・副部長
学術(芸術)賞  
専門分野 血液内科
血栓止血学
輸血医学
現在の研究課題 血友病 血栓 止血 凝固 HIV感染症 輸血医学
担当科目 血栓・止血・凝固・輸血
主な業績等 ADAMTS13 related markers and von Willebrand factor in plasma from patients with thrombotic microangiopathy (TMA). 共著 2008 Thrombosis research 121 849-54
Central venous catheter-related thrombosis after replacement therapy for intracranial bleeding in a patient with afibrinogenaemia. 共著 2008.01 Haemophilia : the official journal of the World Federation of Hemophilia 14 153-6
Negative predictive value of D-dimer for diagnosis of venous thromboembolism. 共著 2008.04 International journal of hematology 87 250-5
The membrane proteinase 3 expression on neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritis. 共著 2008.04 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 14 186-92
Elevated levels of soluble fibrin in patients with venous thromboembolism. 共著 2008.11 International journal of hematology 88 448-53
The effectiveness of measuring for fragmented red cells using an automated hematology analyzer in patients with thrombotic microangiopathy. 2009.05 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 15 257-62
Decreased ADAMTS13 levels in patients after living donor liver transplantation. 共著 2009.11 Thrombosis research 124 541-5
Analysis three abnormal Protein S genes in a patient with pulmonary embolism. 共著 2010.06 Thrombosis research 125 529-32
Elevated Von Willebrand factor propeptide for the diagnosis of thrombotic microangiopathy and for predicting a poor outcome. 共著 2011.01 International journal of hematology 93 47-52
Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients with artificial joint replacement. 共著 2011.10 International journal of hematology 94 355-60
A case of three-year-old boy with severe haemophilia A on prophylaxis identified with a chronic subdural haematoma 2 years after the first episode of acute subdural bleeding. 共著 2012.01 Haemophilia : the official journal of the World Federation of Hemophilia 18 e1-2
Increased fibrinolysis increases bleeding in orthopedic patients receiving prophylactic fondaparinux. 共著 2012.02 International journal of hematology 95 160-6
Frequent association of thrombophilia in cerebral venous sinus thrombosis. 共著 2012.03 International journal of hematology 95 257-62
Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases. 2012.05 Thrombosis research 129 598-602
Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases. 共著 2012.05 Thrombosis research 129 598-602
Diagnostic criteria and laboratory tests for disseminated intravascular coagulation. 2012.12 Expert review of hematology 5 643-52
A prospective analysis of disseminated intravascular coagulation in patients with infections. 共著 2013 Internal medicine (Tokyo, Japan) 52 1893-8
Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation. 共著 2013.03 Thrombosis research 131 225-9
Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases. 共著 2013.03 International journal of hematology 97 345-50
The relationships among hemostatic markers, the withdrawal of fondaparinux due to a reduction in hemoglobin and deep vein thrombosis in Japanese patients undergoing major orthopedic surgery. 共著 2013.10 Clinica chimica acta; international journal of clinical chemistry 425 109-13
Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. 共著 2014 Journal of intensive care 2 15-
Elevated fibrin-related markers in patients with malignant diseases frequently associated with disseminated intravascular coagulation and venous thromboembolism. 共著 2014 Internal medicine (Tokyo, Japan) 53 413-9
Disseminated intravascular coagulation: Testing and diagnosis. 共著 2014.04 Clinica chimica acta; international journal of clinical chemistry
Is early treatment of disseminated intravascular coagulation beneficial in septic patients? 共著 2014.07 Critical care (London, England) 18 447-
Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial. 共著 2014.10 Journal of hypertension 32 2054-63; discussiom 2063
Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation. 2014.11 International journal of hematology 100 437-42
Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxaban. 共著 2014.11 International journal of hematology 100 450-6
Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. 共著 2014.11 Seminars in thrombosis and hemostasis 40 866-73
Successful treatment of non-invasive bladder tumour in a haemophilia A patient with high-responding inhibitors: a case report. 共著 2014.11 Haemophilia : the official journal of the World Federation of Hemophilia 20 e399-401
Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study: comment. 2015.04 Journal of thrombosis and haemostasis : JTH 13 679-80
Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers. 共著 2015.04 Journal of thrombosis and haemostasis : JTH 13 684-5
New Insights of the Tissue Factor Pathway Inhibitor in Patients with Hypercholesterolemia Treated with Statins. 共著 2015.07 Journal of atherosclerosis and thrombosis 22 654-5
High frequency of decreased antithrombin level in pregnant women with thrombosis. 共著 2015.09 International journal of hematology 102 253-8
Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura. 2016 Internal medicine (Tokyo, Japan) 55 589-95
The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC. 共著 2016.02 International journal of hematology 103 173-9
Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with fondaparinux. 共著 2016.05 International journal of hematology 103 554-9
Fibrin-related markers for diagnosing acute-, subclinical-, and pre-venous thromboembolism in patients with major orthopedic surgery. 共著 2016.05 International journal of hematology 103 560-6
Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH: comment. 共著 2016.06 Journal of thrombosis and haemostasis : JTH 14 1314-5
Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials: comment. 共著 2016.11 Journal of thrombosis and haemostasis : JTH 14 2308-2309
Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is 'shock liver' the unrecognized provocateur of ischemic limb necrosis: comment. 共著 2016.11 Journal of thrombosis and haemostasis : JTH 14 2315-2316
The valuable diagnosis of DIC and pre-DIC and prediction of a poor outcome by the evaluation of diagnostic criteria for DIC in patients with hematopoietic injury established by the Japanese Society of Thrombosis and Hemostasis. 共著 2016.11 Thrombosis research 147 80-84
Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with direct oral anticoagulant. 共著 2017 Thrombosis journal 15 27-
Hypofibrinogenemia and the alpha-Fibrinogen Thr312Ala Polymorphism may be Risk Factors for Early Pregnancy Loss. 共著 2017.01 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 23 52-57
The Evaluation of D-Dimer Levels for the Comparison of Fibrinogen and Fibrin Units Using Different D-Dimer Kits to Diagnose VTE. 共著 2017.01 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 1076029617706755-
High prevalence of congenital thrombophilia in patients with pregnancy-related or idiopathic venous thromboembolism/pulmonary embolism. 2017.03 International journal of hematology 105 272-279
Elevated Soluble Platelet Glycoprotein VI Levels in Patients After Living Donor Liver Transplantation. 共著 2017.04 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 23 274-281
An Evaluation of the Modified Diagnostic Criteria for DIC Established by the Japanese Society of Thrombosis and Hemostasis. 共著 2017.09 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 23 579-584
Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome. 共著 2017.09 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 23 622-630
Attempt to Harvest a Sufficient Number of Mononuclear Cells in an Appropriate Blood Product Volume By Modification of the Default Apheresis Setting. 共著 2017.10 Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Soc 21 507-511
Evaluation of the Diagnostic Criteria for the Basic Type of DIC Established by the Japanese Society of Thrombosis and Hemostasis. 共著 2017.10 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 23 838-843
Emicizumab Prophylaxis in Hemophilia A with Inhibitors. 共著 2017.11 The New England journal of medicine 377 2193-4
Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy. 2018 Thrombosis journal 16 14-
The Evaluation of Fibrin-Related Markers for Diagnosing or Predicting Acute or Subclinical Venous Thromboembolism in Patients Undergoing Major Orthopedic Surgery. 共著 2018.01 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 24 107-114
Monitoring of hemostatic abnormalities in major orthopedic surgery patients treated with edoxaban by APTT waveform. 2018.02 International journal of laboratory hematology 40 49-55
The Evaluation of D-Dimer Levels for the Comparison of Fibrinogen and Fibrin Units Using Different D-Dimer Kits to Diagnose VTE. 共著 2018.05 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 24 655-662
Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa/factor X bispecific antibody emicizumab: comment. 2018.06 Journal of thrombosis and haemostasis : JTH
【出血性疾患と血栓性疾患 これを読めば貴方も二刀流】 セミナー 実地医家が知っておくべき最新の知見 血栓性微小血管症(TMA)の鑑別診断 共著 2018.07 Medical Practice 35 1061-1065
An Evaluation of the Activated Partial Thromboplastin Time Waveform. 共著 2018.07 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/H 24 764-770
An Evaluation of the Activated Partial Thromboplastin Time Waveform. 共著 2018.07 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 24 764-770
The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis. 共著 2018.09 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 24 920-927
An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform. 共著 2018.10 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 24 1170-1176
Congenital Thrombophilia in Patients With Superior Mesenteric Venous Thrombosis or Portal Vein Thrombosis. 共著 2018.10 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 24 1117-1121
【徹底ガイド DICのすべて 2019-20】(VIII章)基礎病態と治療 造血器悪性腫瘍 単著 2018.11 救急・集中治療 30 229-233
【徹底ガイド DICのすべて 2019-20】(VII章)診断と治療の指針 ISTH DIC診療ガイダンス 共著 2018.11 救急・集中治療 30 229-233
Clinical Manifestation of Patients With Atypical Hemolytic Uremic Syndrome With the C3 p.I1157T Variation in the Kinki Region of Japan. 共著 2018.11 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 24 1301-1307
【血栓止血の臨床-研修医のために[第2版]】出血性疾患の治療(血液製剤など) 新鮮凍結血漿の適正使用 単著 2018.12 日本血栓止血学会誌 29 734-736
Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk. 共著 2019 Thrombosis journal 17 12-
Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor. 単著 2019.01 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/H 25 1076029618824419-
Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor. 2019.01 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 25 1076029618824419-
Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti-idiotype monoclonal antibodies: comment. 共著 2019.03 Journal of thrombosis and haemostasis : JTH 17 555-556
Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti-idiotype monoclonal antibodies: comment. 共著 2019.03 Journal of thrombosis and haemostasis : JTH 17 555-556
Clinicopathological features of TAFRO syndrome complicated by acquired hemophilia A and development of cardiopulmonary arrest that were successfully treated with VA-ECMO and tocilizumab. 2019.06 International journal of hematology 109 737-743
Life-Threatening Tongue and Retropharyngeal Hemorrhage in a Patient with Hemophilia A with Inhibitors. 共著 2019.07 The American journal of case reports 20 1022-1026